Sparsentan for treating focal segmental glomerulosclerosis in people 8 years and over [ID3955]

  • Awaiting development
  • GID-TA10867
  • Expected publication date: TBC

Status:
Awaiting development
Decision:
None selected
Process:
TA
ID number:
3955

For further information on our processes and methods, please see our CHTE processes and methods manual